BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai X, Li RZ, Jiang ZB, Wei CL, Luo LX, Yao XJ, Li GP, Leung EL. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. Front Pharmacol 2018;9:558. [PMID: 29892225 DOI: 10.3389/fphar.2018.00558] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
2 Yu CP, Li PY, Chen SY, Lin SP, Hou YC. Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration. Molecules 2021;26:7390. [PMID: 34885972 DOI: 10.3390/molecules26237390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bach D, Kim D, Lee SK. Cancer Chemopreventive Potential of Epidermal Growth Factor Receptor Inhibitors from Natural Products. Natural Products for Cancer Chemoprevention 2020. [DOI: 10.1007/978-3-030-39855-2_14] [Reference Citation Analysis]
4 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
5 Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga R, Berindan-Neagoe I. Progress in Research on the Role of Flavonoids in Lung Cancer. Int J Mol Sci 2019;20:E4291. [PMID: 31480720 DOI: 10.3390/ijms20174291] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
6 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 23.3] [Reference Citation Analysis]
7 Lee JS, Sul JY, Park JB, Lee MS, Cha EY, Ko YB. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway. Int J Mol Med 2019;43:1969-78. [PMID: 30864681 DOI: 10.3892/ijmm.2019.4122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhu J, Xu S, Gao W, Feng J, Zhao G. Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. Life Sciences 2019;221:204-11. [DOI: 10.1016/j.lfs.2019.01.046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]